Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Vertex: Improved Outlook Despite First Quarter Miss (Rating Upgrade)
08:04am, Tuesday, 06'th May 2025
Vertex Pharmaceuticals missed Q1 revenue and EPS estimates but this is not a cause for concern as the full-year outlook has improved. Alyftrek is off to a good start and early launch metrics of Journa
Vertex Pharmaceuticals Incorporated (VRTX) Q1 2025 Earnings Call Transcript
08:01pm, Monday, 05'th May 2025
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Company Participants Susie Lisa - SVP, IR Reshma Kewalramani - CEO, President & Director Stua
Vertex Pharmaceuticals (VRTX) Misses Q1 Earnings and Revenue Estimates
06:15pm, Monday, 05'th May 2025
Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $4.06 per share, missing the Zacks Consensus Estimate of $4.22 per share. This compares to earnings of $4.76 per share a year ago.
Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug
04:18pm, Monday, 05'th May 2025
Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday, due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta.
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum?
02:59pm, Monday, 05'th May 2025
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) will report its first-quarter earnings on Monday. As the company reports after market hours, Wall Street expects $4.32 in EPS and $2.85 billion in revenues.
Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now
07:00am, Monday, 05'th May 2025
In 2025, Wall Street has been rattled with increasing concerns about U.S.-China trade wars, escalating geopolitical pressures, rising economic uncertainties, and growing recession fears. The benchmark
3 No-Brainer Stocks to Buy in May
06:45am, Monday, 05'th May 2025
Any time is a great time to buy stocks -- if you pick the right stocks. That's true even in May, a month where some investors have traditionally opted to take a break from the stock market for the sum
5 Growth Stocks to Buy in May and Go Away
04:42am, Sunday, 04'th May 2025
Nearly every investor has heard the adage, "Sell in May and go away." The premise is that stock market returns are often lower between May and October than from November to April.
Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know
06:55pm, Wednesday, 30'th Apr 2025
Vertex Pharmaceuticals (VRTX) reachead $509.47 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.
Final Trades: Berkshire Hathaway, Vertex Pharma, S&P Global and CME Group
01:38pm, Wednesday, 30'th Apr 2025
Final Trades are in! The Investment Committee reveals their top picks to close out the day—don't miss it!
What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings
10:20am, Wednesday, 30'th Apr 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vertex (VRTX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
11:45am, Tuesday, 29'th Apr 2025
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
11:30am, Tuesday, 29'th Apr 2025
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals sa
Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?
08:55am, Tuesday, 29'th Apr 2025
On VRTX's first-quarter earnings call, investors are likely to focus on the launch preparation for Alyftrek (vanza triple) and Journavx (suzetrigine).
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:05am, Monday, 28'th Apr 2025
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
